South Africa’s health regulator authorizes Sinopharm COVID-19 vaccine
Category: #headlines |   By Pankaj Singh |   Date: 2022-02-08

South Africa’s health regulator authorizes Sinopharm COVID-19 vaccine

The South African health regulator has reportedly approved Sinopharm, a COVID-19 vaccination from China. A senior health executive claimed that the government doesn’t plan to acquire vaccine doses for now.

South Africa, which has been hit the hardest by the COVID-19 pandemic in terms of infections and deaths, has deployed the Pfizer-BioNTech and Johnson & Johnson (J&J) vaccines in its vaccination campaign after negotiating supply agreements with the two American pharmaceutical corporations.

However, due to an overstock of vaccines, the government postponed certain vaccination distribution programs scheduled late last year, as uncertainty slowed the uptake.

According to SAHPRA, the vaccine was approved on the basis of accepted safety, quality, and efficacy evidence given by MC Pharma, which is a local regulatory pharmaceutical business that has collaborated with Sinopharm.

The vaccine has been approved for those aged 18 and above, subject to certain restrictions, including that it has to be given in accordance with the national vaccination schedule and that periodic safety updates are provided.

Nicholas Crisp, Deputy Director-General of the health department stated that they would not be purchasing the vaccines as of now, since plenty of stock is available in stores.

For those unaware, the World Health Organization (WHO) approved a Sinopharm COVID-19 vaccine for emergency use in May. Clinical trials revealed that it was less effective against symptomatic disease than the Pfizer-developed injection.

In December, the WHO urged that persons who had received an inactivated COVID-19 vaccination, made by Sinopharm, Sinovac Biotech, and Bharat Biotech in India, have a booster dose to counter fading immunity.

Inactivated vaccinations work by using chemicals, heat, or radiation to inactivate or destroy the SARS-CoV-2 virus. It is worth mentioning here that around 42% of South Africa's adult population which is around 40 million people has been fully vaccinated so far.

 

Source Credit:

https://www.msn.com/en-us/news/other/south-african-regulator-approves-sinopharm-covid-vaccine/ar-AATy3nm?ocid=bingcovid

  • shareShare
  • Twitter
  • Facebook
  • LinkedIn


About Author

Pankaj Singh     Twitter

Pankaj Singh

With a commendable experience of content creation under his belt, Pankaj Singh, a qualified Post Graduate in Management, boasts of having worked as a freelance writer and an insurance underwriter. Additionally, Pankaj has also enriched his qualification portfolio with Read more...

More News By Pankaj Singh

U.K.’s economy to slump worse than other countries in 2023, says IMF

U.K.’s economy to slump worse than other countries in 2023, says IMF

By Pankaj Singh

The U.K. economy is reportedly set to decline and perform worse as compared to other major nations, notably Russia, as the cost of living remains high, as per the International Monetary Fund (IMF). According to the IMF, the economic output would d...

Oil prices hike as China curbs travel rules and US fights winter storm

Oil prices hike as China curbs travel rules and US fights winter storm

By Pankaj Singh

Oil prices reportedly surged to record a three-week high as China lifted its zero-covid policy and extremely cold weather in the United States forced refinery closures along the critical Texas Gulf Coast. Brent crude rose 88 US cents, or 1.1%, to ...

EU accepts carbon market access for $21.3 billion in the energy shift

EU accepts carbon market access for $21.3 billion in the energy shift

By Pankaj Singh

The European Union (EU) policymakers have reportedly agreed to raise nearly $21.3 billion (€20 billion) from the carbon market of that region, to support financing the bloc's strategy to alleviate its reliance on Russia for natural gas in a ...